Marianna Mazza
Rome, ROMA, 00168, Italy
NCT Number: NCT06884033
Group cinematherapy program in reducing depressive and anxiety symptoms in women diagnosed with Depressive Disorders and Anxiety Disorders.
Looking for future studies?
Notify Me18 year–75 year
Female
Interventional
Not applicable
Rome, ROMA, 00168, Italy
Cinematherapy is a creative therapeutic intervention in which a trained professional prescribes the patient to watch a film and uses the characters and themes as metaphors to promote self-exploration and change. The effectiveness of cinematherapy as a therapeutic technique has been demonstrated through its effectiveness in improving participants' self-esteem, emotional expression and understanding, and interpersonal relationships, and in reducing depressive and anxious symptoms.The cinematherapy intervention involves a targeted selection of film content and activities designed to improve the patients' mental condition.The study includes eight meetings on a monthly basis (programming of eight films lasting approximately two hours and subsequent discussion on the contents of the film shown).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cinematherapy, also known as cinema therapy and movie therapy, involves therapist-directed viewing of movies for specific therapeutic purposes.
Time frame: 8 months
The presence and degree of anxiety will be assessed using the Hamilton Anxiety Rating Scale (HARS). The scale consists of 14 items designed to assess the severity of a patient's anxiety. Each of the 14 items contains a number of symptoms, and each group of symptoms is rated on a scale of zero to four, with four being the most severe. A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity.
Time frame: 8 months
The presence and degree of depression will be assessed using the Hamilton Depression Rating Scale (HDRS). The scale contains 17 items pertaining to symptoms of depression experienced over the past week. A score of 0-7 is generally accepted to be within the normal range (or in clinical remission), while a score of 20 or higher (indicating at least moderate severity) is usually required for entry into a clinical trial.
Time frame: 8 months
Weight in kilograms will be collected for all patients.
Time frame: 8 months
Height in metres will be collected for all patients.
Time frame: 8 months
Body mass index, or BMI, gives an indication of body size. BMI is calculated using weight and height (weight in kilograms divided by height in metres squared).The formula is BMI = kg/m2; kg is a person's weight in kilograms and m2 is height in metres squared. BMI can help estimate risk of a heart attack or stroke.
Time frame: 8 months
HRV is a measure of the variation in time between each heartbeat in electrocardiogram . It is used as a reliable, noninvasive method of measuring physiological responses to stress. A consistent baseline score of 70 or higher is associated with health; whereas levels between 50 and 70 are compromised health and diseases; whereas a regular HRV below 50 puts the person at risk for catastrophic illness and even death.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
GINEMOTION: Cinematherapy for Women With Depression and Anxiety
Acronym: GINEMOTION
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07716657
Depression Anxiety Disorder, Self-Criticism
São Cristóvão, Sergipe, Brazil
View Trial DetailsNCT07558772
Anxiety, Anxiety Disorders
Beijing, Beijing Municipality, China
View Trial DetailsNCT05963308
Adjustment Disorder With Anxious Mood, Adjustment Disorder With Depressed Mood
Montreal, Quebec, Canada
View Trial DetailsNCT07545551
Depression Anxiety Disorder, Grief
Ankara, Turkey (Türkiye)
View Trial Details